sorafenib has been researched along with dimethylenastron in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (dimethylenastron) | Trials (dimethylenastron) | Recent Studies (post-2010) (dimethylenastron) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 17 | 0 | 9 |
| Protein | Taxonomy | sorafenib (IC50) | dimethylenastron (IC50) |
|---|---|---|---|
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mostafa, AS; Selim, KB | 1 |
1 other study(ies) available for sorafenib and dimethylenastron
| Article | Year |
|---|---|
Synthesis and anticancer activity of new dihydropyrimidinone derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Neoplasms; Pyrimidinones; TOR Serine-Threonine Kinases | 2018 |